Risk of metastasis in melanoma

Results from a recent population-based cohort study have revealed that female melanoma patients have a lower risk of metastasis compared to males, and better survival

This study aimed to investigate differences in survival between genders for 11,744 cases of cutaneous melanoma taken from the Munich Cancer Registry.
The main outcome measures were survival, regional and systemic progression, and survival after progression.

The study showed the women had higher melanoma specific survival, were at lower risk of disease progression and had significant survival advantage after first progression. There was a lower risk of metastasis in women with localised melanoma than in men.
Joosee A, de Vries E, Eckel R et al. J Invest Dermatol 2011; 131: 719-26

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

MIMS Product Slides

Product overviews prepared by the MIMS team, in a handy slide format.

Click here

Slides are initiated, funded & reviewed by the companies specified.

MIMS app

Access the full drug database and quick-reference tables on the go

Find out more